HER2-Targeted Radioimmunotherapy Yields Complete and Lasting Remission in Breast Cancer Model
A groundbreaking development in the treatment of HER2-positive breast cancer has emerged, heralding a new era in radioimmunotherapy that promises...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
A groundbreaking development in the treatment of HER2-positive breast cancer has emerged, heralding a new era in radioimmunotherapy that promises...
In a significant stride toward combating oral cancer and its burdensome complications, researchers at the School of Dentistry at UT...
In a groundbreaking study poised to reshape the future of cancer therapeutics, researchers have unveiled a novel approach to reactivating...
Early-phase clinical data are increasingly shedding light on groundbreaking therapeutic strategies that harness the body's own immune defenses to combat...
In a groundbreaking review published recently in Current Molecular Pharmacology, researchers have unveiled the sophisticated molecular architecture governing TCF/LEF-mediated transcription...
As cancer treatment continuously evolves, immunotherapy remains at the forefront of transformative advances. At the 2025 Society for Immunotherapy of...
Tumor invasion represents a pivotal and intricate phase in the progression of cancer metastasis, marking the transition from localized malignancy...
In a groundbreaking study published in iScience on October 28th, 2025, researchers have unveiled novel insights into the selective modification...
In a groundbreaking retrospective multicenter study, researchers have shed new light on the clinical features and prognostic factors influencing ovarian...
In the rapidly evolving field of medicine, artificial intelligence (AI) has emerged as a transformative force, particularly in computational pathology...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine